medRxiv PreprintsInternational14 October 2026
Menstrual symptoms and infertility odds among individuals with co-occurring endometriosis and polyendocrine metabolic ovarian syndrome
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Objective: To study the prevalence of co-occurring endometriosis and polyendocrine metabolic ovarian syndrome (PMOS), estimate infertility odds, and characterize menstrual symptom profiles associated with this combined phenotype in a population cohort. Design: Prospective digital cohort in the United States (US). Subjects: 90,714 consented participants enrolled between November 2019 and June 2025 who completed relevant surveys; a subset of 25,152 participants with menstrual cycle logs linked to monthly surveys contributed to symptom analyses. Exposure: Participants were classified by self-repo
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- OSS-DBS v2: Simulation Platform for Biophysical Modelling of Deep Brain Stimulation14 October 2026
- A Growing Burden, a Persistent Gap: Cannabinoid Hyperemesis Syndrome Education and Emergency Department Trends in Michigans Legal Cannabis Market14 October 2026
- Enhanced local synchronization with impaired large-scale recruitment of NREM slow waves in pediatric disorders of arousal14 October 2026
- Bench Testing of an 8 N Slip Resistance Specification for the Handle Shaft Locking Interface of an Articulated Laparoscopic Instrument14 October 2026
- Neurophysiological monitoring of sport related concussion: From diagnosis to return to play14 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.